Skip to main content

Year: 2026

Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK

Approval is based on results from the OASIS 4 trial, which investigated semaglutide tablets 25 mg in adults living with obesity and overweight versus placebo in addition to diet and exercise Semaglutide tablets will be available as a once-daily treatment, an alternative to weekly injections for adults living with obesity or overweight with a weight-related condition, alongside diet and exercise After this approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), Novo Nordisk anticipates Wegovy® pill will be available via private prescription within weeksBagsværd, Denmark, 11 June 2026 – Wegovy® pill, the new daily weight management tablet, has been approved in the UK as an adjunct to a reduced-calorie diet and increased physical activity, offering a first-of-its-kind alternative to injectable treatments for...

Continue reading

Old National Bank Awarded Bauer Financial 5-Star Superior Rating for Financial Strength and Stability

EVANSVILLE, Ind., June 11, 2026 (GLOBE NEWSWIRE) — (NASDAQ: ONB) – Old National Bank, a wholly-owned banking subsidiary of Old National Bancorp (“Old National”), has been awarded Bauer Financials’ 5-Star “Superior” rating, the highest distinction for financial strength and stability. Bauer Financial, Inc., (“Bauer Financial”) is the nation’s leading independent bank rating firm whose 5-Star “Superior” rating recognizes institutions with exceptional financial performance, and are considered among the strongest in the country. “This recognition reinforces the disciplined way we manage our business and the trust our clients place in us each and every day,” said Jim Ryan, Chairman and CEO of Old National. “We remain focused on long-term strength, prudent risk management, and consistently delivering value for our clients and communities....

Continue reading

Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

Media Release COPENHAGEN, Denmark; June 11, 2026Findings from a post-hoc subgroup analysis of the Phase 3 EPCORE® FL-1 trial reinforce fixed-duration epcoritamab in combination with rituximab and lenalidomide (R2 ) data across subgroups in this trial of relapsed or refractory (R/R) follicular lymphoma (FL) patients treated in the second-line or later setting Epcoritamab in combination with R2 demonstrated sustained efficacy with manageable safety, regardless of baseline risk factors, including those traditionally associated with higher- or lower-risk disease factors Data were presented during an oral presentation at the 2026 European Hematology Association (EHA) CongressGenmab A/S (Nasdaq: GMAB) today announced new data from a post-hoc subgroup analysis from the pivotal Phase 3 EPCORE® FL-1 trial, evaluating epcoritamab, a subcutaneous...

Continue reading

Xcel Brands Announces License Agreement for Trust. Respect. Love by Cesar Millan with EcoStrong

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) — Xcel Brands (NASDAQ: XELB), an industry-leading media and consumer products company specializing in building influencer led brands through social commerce and livestream shopping, is pleased to announce a new licensing partnership for Trust. Respect. Love by Cesar Millan with licensing partner EcoStrong for product categories that include cleaning products, odor management, shampoo and conditioners. The partnership will introduce a collection of innovative pet care, pet shampoo, and home cleaning products inspired by Cesar Millan’s philosophy that trust, respect, and love are the foundation of every meaningful relationship between pets and their owners. The collection includes environmentally safe cleaning, grooming, and odor control solutions designed to support healthier homes and happier...

Continue reading

Hotel101-Madrid once again reached 100% occupancy yesterday, June 10, 2026, with all rooms sold out significantly prior to the close of the day

Hotel101-Madrid marked its third month of operations since its opening last March 10, 2026, achieving several full occupancy performances in the recent weeks, demonstrating sustained market demand. This solidifies the continued growth in recurring room demand at the 680-room Hotel101 in Madrid as room bookings continue to surge. In just the past 30 days, Hotel101-Madrid generated over USD2.3 million from recurring room revenues alone. On June 10, 2026, Hotel101-Madrid recorded single-day room revenue exceeding USD100,000. This marks another strong day as average daily room revenues have continued to rise compared with the hotel’s first month of operations. Management believes that the Hotel101 global prototype has now been polished and calibrated and is ready to hyperscale. Management intends to accelerate the replication of the cookie...

Continue reading

NBPE: NB Private Equity Partners Announces the Results of the Annual General Meeting

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSSt Peter Port, Guernsey   11 June 2026 NB Private Equity Partners Limited (the “Company”) is pleased to announce that at the Annual General Meeting of its Class A Shareholders held at 2.00 p.m. on 11 June 2026, each of the Resolutions tabled were duly passed without amendment. All resolutions as set out in the Notice of AGM, of which resolutions 1-12 were proposed as ordinary resolutions and resolutions 13-15 were proposed as special resolutions, were voted on by way of a poll and the results were as follows:Resolution Votes For % votes cast Votes Against % votes cast Votes Withheld*1. To receive the Audited Financial Statements and Directors...

Continue reading

Unity Bank Appoints Sara M. Sooy and Alfred J. Gaburo to Board of Directors

New directors bring extensive experience in government affairs, financial oversight, banking, real estate finance, and community leadershipHeadshot – Sara M. SooySara M. SooyHeadshot – Alfred J. GaburoAlfred J. GaburoCLINTON, N.J., June 11, 2026 (GLOBE NEWSWIRE) — Unity Bancorp, Inc. (NASDAQ: UNTY), the parent company of Unity Bank, announced that its Board of Directors has voted to appoint Sara M. Sooy and Alfred J. Gaburo to the Unity Bank Board of Directors. Sooy brings significant banking, finance, governance, and public-sector leadership experience to the board. Her background includes public company audit committee service, credit risk evaluation, commercial real estate finance, enterprise risk governance, capital planning, and fiduciary oversight. She has held roles with Investors Bank and...

Continue reading

Statement regarding intention to fundraise

11 JUNE 2026 NORTHERN VENTURE TRUST PLC STATEMENT REGARDING INTENTION TO FUNDRAISE Northern Venture Trust PLC (“the Company”) is pleased to announce that, subject to obtaining any required shareholder or regulatory approvals, in conjunction with Northern 2 VCT PLC and Northern 3 VCT PLC (together with the Company known as the “Northern VCTs”), it intends to launch a joint offer of new ordinary shares for subscription in the 2026/27 tax year (“the Offer”). It is envisaged that the Offer will seek to raise up to £10 million for the Company. Full details of the Offer will be announced by the Company in due course. The offer is expected to launch in September 2026. Enquiries: Sarah Williams / James Sly, Mercia Fund Management Limited – 0330 223 1430 Website: www.mercia.co.uk/vcts Neither the contents of the Mercia Asset Management PLC...

Continue reading

Statement regarding intention to fundraise

11 JUNE 2026 NORTHERN 2 VCT PLC STATEMENT REGARDING INTENTION TO FUNDRAISE Northern 2 VCT PLC (“the Company”) is pleased to announce that, subject to obtaining any required shareholder or regulatory approvals, in conjunction with Northern Venture Trust PLC and Northern 3 VCT PLC (together with the Company known as the “Northern VCTs”), it intends to launch a joint offer of new ordinary shares for subscription in the 2026/27 tax year (“the Offer”). It is envisaged that the Offer will seek to raise up to £10 million for the Company. Full details of the Offer will be announced by the Company in due course. The offer is expected to launch in September 2026. Enquiries: Sarah Williams / James Sly, Mercia Fund Management Limited – 0330 223 1430 Website: www.mercia.co.uk/vcts Neither the contents of the Mercia Asset Management PLC website,...

Continue reading

Statement regarding intention to fundraise

11 JUNE 2026 NORTHERN 3 VCT PLC STATEMENT REGARDING INTENTION TO FUNDRAISE Northern 3 VCT PLC (“the Company”) is pleased to announce that, subject to obtaining any required shareholder or regulatory approvals, in conjunction with Northern Venture Trust PLC and Northern 2 VCT PLC (together with the Company known as the “Northern VCTs”), it intends to launch a joint offer of new ordinary shares for subscription in the 2026/27 tax year (“the Offer”). It is envisaged that the Offer will seek to raise up to £10 million for the Company. Full details of the Offer will be announced by the Company in due course. The offer is expected to launch in September 2026. Enquiries: Sarah Williams / James Sly, Mercia Fund Management Limited – 0330 223 1430 Website: www.mercia.co.uk/vcts Neither the contents of the Mercia Asset Management PLC website,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.